rs1057035

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_177438.3(DICER1):​c.*2693A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.271 in 233,052 control chromosomes in the GnomAD database, including 10,371 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 6358 hom., cov: 32)
Exomes 𝑓: 0.30 ( 4013 hom. )

Consequence

DICER1
NM_177438.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.256

Publications

73 publications found
Variant links:
Genes affected
DICER1 (HGNC:17098): (dicer 1, ribonuclease III) This gene encodes a protein possessing an RNA helicase motif containing a DEXH box in its amino terminus and an RNA motif in the carboxy terminus. The encoded protein functions as a ribonuclease and is required by the RNA interference and small temporal RNA (stRNA) pathways to produce the active small RNA component that represses gene expression. This protein also acts as a strong antiviral agent with activity against RNA viruses, including the Zika and SARS-CoV-2 viruses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2021]
DICER1 Gene-Disease associations (from GenCC):
  • DICER1-related tumor predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • pleuropulmonary blastoma
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • DICER1 syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 14-95087805-T-C is Benign according to our data. Variant chr14-95087805-T-C is described in ClinVar as Benign. ClinVar VariationId is 315063.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.358 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DICER1NM_177438.3 linkc.*2693A>G 3_prime_UTR_variant Exon 27 of 27 ENST00000343455.8 NP_803187.1 Q9UPY3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DICER1ENST00000343455.8 linkc.*2693A>G 3_prime_UTR_variant Exon 27 of 27 1 NM_177438.3 ENSP00000343745.3 Q9UPY3-1

Frequencies

GnomAD3 genomes
AF:
0.258
AC:
39172
AN:
152014
Hom.:
6360
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0800
Gnomad AMI
AF:
0.490
Gnomad AMR
AF:
0.318
Gnomad ASJ
AF:
0.309
Gnomad EAS
AF:
0.136
Gnomad SAS
AF:
0.0859
Gnomad FIN
AF:
0.295
Gnomad MID
AF:
0.212
Gnomad NFE
AF:
0.362
Gnomad OTH
AF:
0.273
GnomAD4 exome
AF:
0.298
AC:
24079
AN:
80920
Hom.:
4013
Cov.:
0
AF XY:
0.297
AC XY:
11063
AN XY:
37190
show subpopulations
African (AFR)
AF:
0.0814
AC:
317
AN:
3892
American (AMR)
AF:
0.336
AC:
839
AN:
2500
Ashkenazi Jewish (ASJ)
AF:
0.329
AC:
1684
AN:
5118
East Asian (EAS)
AF:
0.112
AC:
1273
AN:
11398
South Asian (SAS)
AF:
0.107
AC:
75
AN:
700
European-Finnish (FIN)
AF:
0.288
AC:
19
AN:
66
Middle Eastern (MID)
AF:
0.205
AC:
101
AN:
492
European-Non Finnish (NFE)
AF:
0.355
AC:
17731
AN:
49990
Other (OTH)
AF:
0.302
AC:
2040
AN:
6764
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
878
1756
2635
3513
4391
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.257
AC:
39171
AN:
152132
Hom.:
6358
Cov.:
32
AF XY:
0.251
AC XY:
18665
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.0799
AC:
3317
AN:
41530
American (AMR)
AF:
0.318
AC:
4855
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.309
AC:
1070
AN:
3466
East Asian (EAS)
AF:
0.135
AC:
700
AN:
5172
South Asian (SAS)
AF:
0.0857
AC:
414
AN:
4828
European-Finnish (FIN)
AF:
0.295
AC:
3113
AN:
10564
Middle Eastern (MID)
AF:
0.211
AC:
62
AN:
294
European-Non Finnish (NFE)
AF:
0.362
AC:
24624
AN:
67974
Other (OTH)
AF:
0.270
AC:
570
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1366
2733
4099
5466
6832
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
392
784
1176
1568
1960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.309
Hom.:
17218
Bravo
AF:
0.256
Asia WGS
AF:
0.126
AC:
440
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

DICER1-related tumor predisposition Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.92
DANN
Benign
0.55
PhyloP100
0.26
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1057035; hg19: chr14-95554142; API